US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

INVESCO BIOTECHNOLOGY & GENOME ETF

96.94

+0.26000.27%

Post-market: 96.940.00000.00%16:10 EDT

Volume:9K

Turnover:882.18K

Market Cap:399.39M

PE:54.06

High:96.95

Open:96.84

Low:96.67

Close:96.68

52wk High:98.82

52wk Low:67.69

Shares:4.12M

Float Shares:4.12M

Volume Ratio:0.47

T/O Rate:0.22%

Dividend:1.55

Dividend Rate:1.60%

EPS(TTM):1.79

EPS(LYR):18.65

ROE:24.76%

ROA:0.08%

PB:1.61

PE(LYR):5.20

Loading ...

Overview Company News Filings

Analysts Conflicted on These Healthcare Names: Alnylam Pharma (ALNY), Lakefront Biotherapeutics (LKFT) and BioNTech SE (BNTX)

Amgen Says Repatha Cuts Death Risk 20% in High-Risk Patients

MT Newswires Live

Analysts Are Bullish on These Healthcare Stocks: Boston Scientific (BSX), Alnylam Pharma (ALNY)

Amgen Repatha reduces risk of death in high-risk adults for first heart attack

Amgen's Repatha® Reduces Risk of Death in Patients at High Risk for a First Heart Attack or Stroke

THOMSON REUTERS

Alnylam announces new data at ESC Congress on AMVUTTRA

Crinetics Shareholders Approve Vertex Acquisition at Special Meeting

Biogen Inc. Stock Underperforms Friday When Compared to Competitors

Amgen Inc. Stock Underperforms Friday When Compared to Competitors

Vertex Tests VX-407’s Impact on Birth Control: What It Means for VRTX Investors

Amgen’s Pediatric Psoriasis Study Wrap-Up: What Apremilast Safety Data Means for Investors

Alnylam, Ionis Fall as Heart-Drug Data Raise Doubts over Combination Treatment

Political and General News Events from August 28

Biogen CEO Viehbacher to Speak at Morgan Stanley Global Healthcare Conference

Amgen’s AMG 691 Phase 1 Trial Targets Key Growth in Asian Markets

Analysts Offer Insights on Healthcare Companies: Verrica Pharmaceuticals (VRCA) and Amgen (AMGN)

HBM Holdings FY26 H1 Profit Falls 11.16% to US$ 64.85 Million; Revenue Rises 20.9% to US$ 122.49 Million

Amgen, AstraZeneca announce Crossing trial showed ‘meaningful’ improvements

Amgen, AstraZeneca report CROSSING trial met co-primary and secondary endpoints

AstraZeneca, Amgen Phase 3 Trial Shows Tezspire Eases Swallowing Difficulties for EoE Patients

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/PBE/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PBE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBE\",,,,,undefined,":{"symbol":"PBE","market":"US","secType":"STK","nameCN":"INVESCO BIOTECHNOLOGY & GENOME ETF","latestPrice":96.94,"timestamp":1788292800000,"preClose":96.68,"halted":0,"volume":9113,"hourTrading":{"tag":"盘后","latestPrice":96.94,"preClose":96.94,"latestTime":"16:10 EDT","volume":10,"amount":969.4,"timestamp":1788293404935,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.0026892842366569186,"floatShares":4120000,"shares":4120000,"eps":1.793292,"marketStatus":"Post-Mkt","change":0.26,"latestTime":"09-01 17:31:03 EDT","open":96.84,"high":96.95,"low":96.665,"amount":882175,"amplitude":0.002948,"askPrice":102,"askSize":3,"bidPrice":87.82,"bidSize":100,"shortable":3,"etf":1,"ttmEps":1.793292,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1788307200000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":96.68,"sharesOutstanding":3180000,"nav":96.39391,"aum":469438341.7,"dividendRate":0.015957,"bidAskSpread":0.002037,"preHourTrading":{"tag":"盘前","latestPrice":97.83,"preClose":96.68,"latestTime":"05:50 EDT","volume":5,"amount":486.63,"timestamp":1788256220934,"change":1.15,"changeRate":0.011895,"amplitude":0.026065},"postHourTrading":{"tag":"盘后","latestPrice":96.94,"preClose":96.94,"latestTime":"16:10 EDT","volume":10,"amount":969.4,"timestamp":1788293404935,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.470465,"impliedVol":0.1136,"impliedVolPercentile":0.0159},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBE\",,,,,undefined,":{"symbol":"PBE","floatShares":4120000,"roa":"0.08%","roe":"24.76%","lyrEps":18.654418,"volumeRatio":0.470465,"shares":4120000,"dividePrice":1.5469,"high":96.95,"amplitude":0.002948,"preClose":96.68,"low":96.665,"week52Low":67.69,"pbRate":"1.61","psRate":"232.66","week52High":98.82,"institutionHeld":0.2552,"latestPrice":96.94,"committee":0.941748,"eps":1.793292,"divideRate":0.015957,"volume":9113,"delay":0,"ttmEps":1.793292,"open":96.84,"prevYearClose":82.15,"prevWeekClose":96.32,"prevMonthClose":96.68,"prevQuarterClose":89.6486,"fiveDayClose":98.7315,"twentyDayClose":91.53,"sixtyDayClose":83.4781},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PBE\",params:#limit:5,,,undefined,":[{"date":"2026-06-22","symbol":"PBE","amount":0.81061,"announcedDate":"2026-06-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-26","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-26"},{"date":"2026-03-23","symbol":"PBE","amount":0.08244,"announcedDate":"2026-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-23","defaultRemindTime":1774272600000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-27","payableDate":"2026-03-23","currency":"USD","dateTimestamp":1774238400000,"payDate":"2026-03-27"},{"date":"2025-12-22","symbol":"PBE","amount":0.41972,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2025-09-22","symbol":"PBE","amount":0.23409,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-26","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-26"},{"date":"2025-06-23","symbol":"PBE","amount":0.13047,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-27","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-27"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PBE\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-16","recordDate":"2016-09-20","paymentDate":"2016-09-30","value":0.02834,"currency":"USD"},{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-30","value":0.1208,"currency":"USD"},{"executeDate":"2017-03-17","recordDate":"2017-03-21","paymentDate":"2017-03-31","value":0.05552,"currency":"USD"},{"executeDate":"2017-06-16","recordDate":"2017-06-20","paymentDate":"2017-06-30","value":0.21532,"currency":"USD"},{"executeDate":"2018-09-24","recordDate":"2018-09-25","paymentDate":"2018-09-28","value":0.00207,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PBE\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PBE\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2663008638","title":"Analysts Conflicted on These Healthcare Names: Alnylam Pharma (ALNY), Lakefront Biotherapeutics (LKFT) and BioNTech SE (BNTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2663008638","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663008638?lang=en_us&edition=fundamental","pubTime":"2026-08-31 19:50","pubTimestamp":1788177029,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Alnylam Pharma (ALNY), Lakefront Biotherapeutics (LKFT) and BioNT...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-alnylam-pharma-alny-lakefront-biotherapeutics-lkft-and-biontech-se-bntx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-alnylam-pharma-alny-lakefront-biotherapeutics-lkft-and-biontech-se-bntx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","BK4568","LU0320765992.SGD","LU0114720955.EUR","LU0882574055.USD","LU0889565916.HKD","GNMX","BK4581","BK4585","BK4139","LU0128526141.USD","LU0029874061.USD","BK4588","LABU","BK4535","BK4137","XBI","BK4548","LKFT","BK4551","ALNY","XLV","PBE","LU0109394709.USD","BNTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663071381","title":"Amgen Says Repatha Cuts Death Risk 20% in High-Risk Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2663071381","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663071381?lang=en_us&edition=fundamental","pubTime":"2026-08-31 17:51","pubTimestamp":1788169915,"startTime":"0","endTime":"0","summary":"Amgen  said Monday that its cholesterol-lowering drug Repatha reduced the risk of death by 20% in high-risk adults without a prior heart attack or stroke.The findings came from a pre-specified analysis of the phase 3 VESALIUS-CV trial involving more than 12,000 patients and were presented at the European Society of Cardiology Congress 2026 in Munich, it said.Amgen said Repatha reduced both overall and cardiovascular deaths when added to statins or other LDL-C-lowering treatments. The mortality benefit emerged after about 1.5 years and continued through a median follow-up of 4.6 years, it added.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0289739699.SGD","IBB","LU2468319806.SGD","BK4599","LU2089984988.USD","LU2242646821.SGD","LU0320765992.SGD","BK4581","LU1057294990.SGD","IE00BJJMRZ35.SGD","BK4566","PJP","LU0058720904.USD","BK4534","IE00B2B36J28.USD","IE00B4R5TH58.HKD","LU0868494617.USD","LU2112291526.USD","IE00BJT1NW94.SGD","IE0002141913.USD","BIB","IBBQ","LU1983299246.USD","AMGN","LU2242652126.USD","LU1571399168.USD","SG9999001440.SGD","LU1023059063.AUD","TBXU","IE0009355771.USD","LU0122379950.USD","LU1061106388.HKD","PBE","LU0889565916.HKD","LU0109394709.USD","BK4139","BK4585","BBH","BK4533","IE00BFTCPJ56.SGD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663079169","title":"Analysts Are Bullish on These Healthcare Stocks: Boston Scientific (BSX), Alnylam Pharma (ALNY)","url":"https://stock-news.laohu8.com/highlight/detail?id=2663079169","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663079169?lang=en_us&edition=fundamental","pubTime":"2026-08-31 17:30","pubTimestamp":1788168608,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Boston Scientific (BSX) and Alnylam Pharma (ALNY) wi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-boston-scientific-bsx-alnylam-pharma-alny-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-boston-scientific-bsx-alnylam-pharma-alny-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2242649171.HKD","LU2506952170.USD","LU1804176565.USD","LU1791710400.SGD","IE0009355771.USD","LU1989772840.SGD","IE0002141913.USD","XLV","LU0225283273.USD","LU1720051108.HKD","XBI","LU2112291526.USD","LU0138981039.USD","LU1989764664.SGD","LU0320765992.SGD","BK4585","LU0266013472.USD","LU1718418525.SGD","IE00BJJMRZ35.SGD","LU0109394709.USD","HCSG","LU0077335932.USD","LU2506951958.HKD","LU0353189763.USD","LU0889565916.HKD","LU2362540622.SGD","LU0048584097.USD","IE00B4R5TH58.HKD","LU2362541513.USD","LU2491050071.SGD","BK4139","ALNY","BSX","LU2244417387.USD","BK4504","IE00BFTCPJ56.SGD","GNMX","LU0345769631.USD","BK4581","BK4548","LU1153585028.USD","PBE","LU1057294990.SGD","LU0251132253.USD","LU0267386448.USD","LABU","LU1720051017.SGD","LU0114720955.EUR","LU1989764748.USD","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663249076","title":"Amgen Repatha reduces risk of death in high-risk adults for first heart attack","url":"https://stock-news.laohu8.com/highlight/detail?id=2663249076","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663249076?lang=en_us&edition=fundamental","pubTime":"2026-08-31 17:10","pubTimestamp":1788167413,"startTime":"0","endTime":"0","summary":"Amgen (AMGN) announced new findings showing Repatha reduced the risk of death in high-risk adults without a prior heart attack or stroke when added...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/amgen-repatha-reduces-risk-of-death-in-high-risk-adults-for-first-heart-attack-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/amgen-repatha-reduces-risk-of-death-in-high-risk-adults-for-first-heart-attack-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE0002141913.USD","PBE","IBBQ","LU2089984988.USD","IBB","LU0058720904.USD","IE00B4R5TH58.HKD","BK4585","LU0289739699.SGD","LU1057294990.SGD","BK4566","LU0868494617.USD","PJP","LU1571399168.USD","AMGN","BK4139","LU2242646821.SGD","LU0889565916.HKD","IE0009355771.USD","BK4581","BBH","LU2468319806.SGD","TBXU","IE00BFTCPJ56.SGD","LU1983299246.USD","BK4533","IE00B2B36J28.USD","BK4534","LU0320765992.SGD","LU1061106388.HKD","LU2112291526.USD","IE00BJJMRZ35.SGD","LU0109394709.USD","BK4588","LU0122379950.USD","BK4599","IE00BJT1NW94.SGD","BIB","SG9999001440.SGD","LU1023059063.AUD","LU2242652126.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663202044","title":"Amgen's Repatha® Reduces Risk of Death in Patients at High Risk for a First Heart Attack or Stroke","url":"https://stock-news.laohu8.com/highlight/detail?id=2663202044","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663202044?lang=en_us&edition=fundamental","pubTime":"2026-08-31 15:18","pubTimestamp":1788160736,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nTUA6XK0BH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00B4R5TH58.HKD","IBBQ","BBH","PBE","IE0009355771.USD","LU1023059063.AUD","LU1983299246.USD","LU0058720904.USD","BK4139","LU2089984988.USD","LU0289739699.SGD","BK4533","LU1057294990.SGD","LU0868494617.USD","SG9999001440.SGD","LU0122379950.USD","AMGN","IBB","IE0002141913.USD","LU2112291526.USD","IE00BJJMRZ35.SGD","BK4581","BIB","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","BK4588","PJP","LU0320765992.SGD","TBXU","BK4585","BK4599","LU1571399168.USD","IE00BJT1NW94.SGD","LU0109394709.USD","LU2242646821.SGD","LU0889565916.HKD","LU2468319806.SGD","LU2242652126.USD","LU1061106388.HKD","BK4534","BK4566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663047585","title":"Alnylam announces new data at ESC Congress on AMVUTTRA","url":"https://stock-news.laohu8.com/highlight/detail?id=2663047585","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663047585?lang=en_us&edition=fundamental","pubTime":"2026-08-31 04:20","pubTimestamp":1788121206,"startTime":"0","endTime":"0","summary":"Alnylam (ALNY) Pharmaceuticals announced new data at the European Society of Cardiology, ESC, Congress 2026 demonstrating the strength of RNAi-powe...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alnylam-announces-new-data-at-esc-congress-on-amvuttra-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alnylam-announces-new-data-at-esc-congress-on-amvuttra-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALNY","BK4585","GNMX","LU0889565916.HKD","PBE","LU0114720955.EUR","EPV","LU0109394709.USD","LU0320765992.SGD","LU0882574055.USD","BK4139","BK4548","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663015099","title":"Crinetics Shareholders Approve Vertex Acquisition at Special Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2663015099","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663015099?lang=en_us&edition=fundamental","pubTime":"2026-08-29 05:33","pubTimestamp":1787952818,"startTime":"0","endTime":"0","summary":"Crinetics Pharmaceuticals ( ($CRNX) ) has provided an update. On August 28, 2026, Crinetics Pharmaceuticals shareholders held a special meeting at ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/crinetics-shareholders-approve-vertex-acquisition-at-special-meeting?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/crinetics-shareholders-approve-vertex-acquisition-at-special-meeting?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SG9999001176.SGD","LU2468319806.SGD","BK4532","IBBQ","BIB","LU2417539215.USD","IE0009355771.USD","IE0002141913.USD","LU1674673691.USD","BBH","LU1778281490.HKD","IE00B894F039.SGD","LU0061475181.USD","IE00B19Z3B42.SGD","LU0320765992.SGD","BK4585","BK4567","LU0079474960.USD","LU1069344957.HKD","LU2462157665.USD","IDNA","LU0432979614.USD","LU2236285917.USD","IE00BJJMRZ35.SGD","LU2324357040.USD","TBXU","LU0256863811.USD","LU1815336091.USD","LU2362540622.SGD","LU1093756168.USD","LU1674673428.USD","BK4023","LU0289739699.SGD","IE00BZ9MQY76.HKD","IE00B19Z9P08.USD","LU1430594728.SGD","IE00BFTCPJ56.SGD","GNMX","LU0823416689.USD","BK4588","LU0234570918.USD","PBE","LU0757428866.USD","IBB","VERX","BK4533","IE00BJT1NW94.SGD","VRTX","IE00B19Z3581.USD","LU0566484027.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663613015","title":"Biogen Inc. Stock Underperforms Friday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2663613015","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663613015?lang=en_us&edition=fundamental","pubTime":"2026-08-29 04:57","pubTimestamp":1787950620,"startTime":"0","endTime":"0","summary":"DJ Biogen Inc. Stock Underperforms Friday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Biogen Inc.  shed 1.35% to $218.50 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index  falling 0.25% to 7,711.76 and Dow Jones Industrial Average  falling 0.02% to 53,559.99.The stock's fall snapped a five-day winning streak.Biogen Inc. closed 1.95% short of its 52-week high of $222.85, which the company achieved on August 25th.The stock underperformed when compared to some of its competitors Friday, as Johnson & Johnson  rose 0.85% to $268.04, Pfizer Inc.  fell 0.21% to $27.96, and AbbVie Inc.  fell 1.03% to $255.48.Trading volume  remained 667,372 below its 50-day average volume of 1.2 M.Data source: Dow Jones Market Data, FactSet. Data compiled August 28, 2026.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z9P08.USD","LU0109394709.USD","BK4533","BIIB","BMED","BK4532","LU0889565916.HKD","BK4588","IE00B19Z9Z06.USD","BK4139","PBE","LU0234570918.USD","IE00B894F039.SGD","LU0320765992.SGD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663015807","title":"Amgen Inc. Stock Underperforms Friday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2663015807","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663015807?lang=en_us&edition=fundamental","pubTime":"2026-08-29 04:34","pubTimestamp":1787949240,"startTime":"0","endTime":"0","summary":"DJ Amgen Inc. Stock Underperforms Friday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Amgen Inc.  slipped 1.05% to $432.42 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index  falling 0.25% to 7,711.76 and Dow Jones Industrial Average  falling 0.02% to 53,559.99.This was the stock's fourth consecutive day of losses.Amgen Inc. closed 3.27% below its 52-week high of $447.03, which the company reached on August 25th.The stock underperformed when compared to some of its competitors Friday, as Johnson & Johnson  rose 0.85% to $268.04, Pfizer Inc.  fell 0.21% to $27.96, and AbbVie Inc.  fell 1.03% to $255.48.Trading volume  remained 889,592 below its 50-day average volume of 2.6 M.Data source: Dow Jones Market Data, FactSet. Data compiled August 28, 2026.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","BK4585","LU0109394709.USD","LU1061106388.HKD","LU0889565916.HKD","LU1571399168.USD","BK4581","LU0320765992.SGD","LU2112291526.USD","IE00B2B36J28.USD","BK4534","IE00BJT1NW94.SGD","IBB","LU0122379950.USD","BK4533","PJP","LU0058720904.USD","LU2089984988.USD","BK4566","BBH","LU0868494617.USD","LU1023059063.AUD","TBXU","SG9999001440.SGD","IE0002141913.USD","LU1983299246.USD","BIB","BK4588","LU2242646821.SGD","IE00BJJMRZ35.SGD","LU2468319806.SGD","PBE","LU1057294990.SGD","IBBQ","LU2242652126.USD","04332","LU0289739699.SGD","IE0009355771.USD","BK4599","AMGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663097210","title":"Vertex Tests VX-407’s Impact on Birth Control: What It Means for VRTX Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2663097210","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663097210?lang=en_us&edition=fundamental","pubTime":"2026-08-29 00:30","pubTimestamp":1787934634,"startTime":"0","endTime":"0","summary":"Vertex Pharmaceuticals Inc. ($VRTX) announced an update on their ongoing clinical study. Vertex’s new Phase 1 study, officially titled “A Phase 1, ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vertex-tests-vx-407s-impact-on-birth-control-what-it-means-for-vrtx-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vertex-tests-vx-407s-impact-on-birth-control-what-it-means-for-vrtx-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BBH","GNMX","IE0002270589.USD","IE00B19Z3581.USD","PBE","VERX","LU1674673428.USD","LU2237438978.USD","IBBQ","BK4023","LU2362541513.USD","LU2417539215.USD","LU2468319806.SGD","SG9999001176.USD","VRTX","ISBC","LU1585245621.USD","IE00BZ9MQY76.HKD","SGXZ57979304.SGD","LU0889565916.HKD","SG9999001176.SGD","LU1430594728.SGD","BK4588","LU0566484027.USD","LU0823416689.USD","IDNA","LU2362541273.HKD","BK4532","LU0417517546.SGD","LU0058720904.USD","TBXU","IE0009355771.USD","LU2089984988.USD","SG9999013999.USD","LU1815336091.USD","LU1559883803.SGD","IBB","LU0320765992.SGD","BK4211","BIB","LU2324357040.USD","IE00B894F039.SGD","LU1093756325.SGD","IE00BJT1NW94.SGD","BK4567","IE00B19Z9Z06.USD","LU2362540622.SGD","BK4139","IE00B2B36J28.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663225097","title":"Amgen’s Pediatric Psoriasis Study Wrap-Up: What Apremilast Safety Data Means for Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2663225097","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663225097?lang=en_us&edition=fundamental","pubTime":"2026-08-29 00:30","pubTimestamp":1787934627,"startTime":"0","endTime":"0","summary":"Amgen Inc ($AMGN) announced an update on their ongoing clinical study. Amgen’s latest psoriasis study update spotlights apremilast (AMG 407) for ki...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/amgens-pediatric-psoriasis-study-wrap-up-what-apremilast-safety-data-means-for-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/amgens-pediatric-psoriasis-study-wrap-up-what-apremilast-safety-data-means-for-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2242652126.USD","LU2242646821.SGD","BBH","PBE","BIB","LU2468319806.SGD","AMGN","IE0009355771.USD","BK4533","IBBQ","LU1023059063.AUD","LU1057294990.SGD","BK4599","BK4139","SG9999001440.SGD","TBXU","IE00BFTCPJ56.SGD","BK4581","BK4585","IE00B2B36J28.USD","IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","LU0109394709.USD","IE0002141913.USD","LU1061106388.HKD","LU0058720904.USD","BK4211","LU0122379950.USD","BK4566","LU1571399168.USD","BK4534","LU0289739699.SGD","LU1983299246.USD","BK4588","IBB","LU0889565916.HKD","ISBC","LU0868494617.USD","IE00BJJMRZ35.SGD","LU2089984988.USD","LU2112291526.USD","LU0320765992.SGD","PJP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662933990","title":"Alnylam, Ionis Fall as Heart-Drug Data Raise Doubts over Combination Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2662933990","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662933990?lang=en_us&edition=fundamental","pubTime":"2026-08-28 20:43","pubTimestamp":1787921001,"startTime":"0","endTime":"0","summary":"BUZZ-Alnylam, Ionis fall as heart-drug data raise doubts over combination treatment** Shares of Alnylam PharmaceuticalsALNY.Ofall 5.3% to $224, while those of Ionis PharmaceuticalsIONS.Ofall 1.3% to $","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nL4N44P0XT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0114720955.EUR","BK4139","BK4548","IONS","ALNY","BK4588","LU0889565916.HKD","PBE","LU0109394709.USD","LU0320765992.SGD","GNMX","LU0882574055.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662098405","title":"Political and General News Events from August 28","url":"https://stock-news.laohu8.com/highlight/detail?id=2662098405","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662098405?lang=en_us&edition=fundamental","pubTime":"2026-08-28 20:30","pubTimestamp":1787920229,"startTime":"0","endTime":"0","summary":"DIARY-Political and General News Events from August 28Aug 28 (Reuters)-For other diaries, please see:Political andGeneral NewsPOL/DIARYTop Economic EventsM/DIARYEmerging Markets Economic EventsEMRG/DI","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nL4N44P0YN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2242646821.SGD","LU0320765992.SGD","LU2468319806.SGD","BK4566","LU0289739699.SGD","IBBQ","BK4581","BK4533","PBE","BK4599","IE0002141913.USD","IE0009355771.USD","TBXU","LU1571399168.USD","LU0122379950.USD","LU0109394709.USD","SG9999001440.SGD","LU1061106388.HKD","LU0889565916.HKD","IE00B4R5TH58.HKD","AMGN","BK4585","LU2089984988.USD","BK4534","BK4139","LU1057294990.SGD","BIB","PJP","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD","LU1983299246.USD","LU2242652126.USD","BBH","LU1023059063.AUD","BK4588","IBB","IE00B2B36J28.USD","LU0058720904.USD","LU2112291526.USD","IE00BJT1NW94.SGD","LU0868494617.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662389720","title":"Biogen CEO Viehbacher to Speak at Morgan Stanley Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2662389720","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662389720?lang=en_us&edition=fundamental","pubTime":"2026-08-28 04:10","pubTimestamp":1787861436,"startTime":"0","endTime":"0","summary":"Biogen CEO Viehbacher to speak at Morgan Stanley Global Healthcare ConferenceBiogen CEO Christopher A. Viehbacher to join a fireside chat at Morgan Stanley’s 24th Annual Global Healthcare Conference on Sept. 14, 2026.Webcast scheduled for 9:15 a.m. ET.Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Biogen Inc. published the original content used to generate this news brief on August 27, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nNDL8TV47S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4588","IE00B894F039.SGD","BK4532","PBE","BK4139","IE00B19Z9Z06.USD","BMED","BIIB","LU0234570918.USD","IE00B19Z9P08.USD","LU0889565916.HKD","BK4533","LU0320765992.SGD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662084187","title":"Amgen’s AMG 691 Phase 1 Trial Targets Key Growth in Asian Markets","url":"https://stock-news.laohu8.com/highlight/detail?id=2662084187","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662084187?lang=en_us&edition=fundamental","pubTime":"2026-08-28 00:31","pubTimestamp":1787848308,"startTime":"0","endTime":"0","summary":"Amgen Inc ($AMGN) announced an update on their ongoing clinical study. Amgen Inc. (AMGN) has started a new Phase 1 trial called “A Phase 1, Open-La...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/amgens-amg-691-phase-1-trial-targets-key-growth-in-asian-markets?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/amgens-amg-691-phase-1-trial-targets-key-growth-in-asian-markets?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BJJMRZ35.SGD","LU2468319806.SGD","BK4139","LU2242652126.USD","IE0009355771.USD","PBE","IE00B2B36J28.USD","AMGN","LU1983299246.USD","BK4588","LU0109394709.USD","LU0889565916.HKD","LU1061106388.HKD","BK4566","SG9999001440.SGD","LU2242646821.SGD","PJP","LU0289739699.SGD","TBXU","IBBQ","LU0320765992.SGD","BK4533","BBC","BBH","LU0122379950.USD","LU2089984988.USD","BK4534","IE00B4R5TH58.HKD","LU0868494617.USD","LU0058720904.USD","BK4599","IE00BFTCPJ56.SGD","IE0002141913.USD","IE00BJT1NW94.SGD","LU1057294990.SGD","LU1571399168.USD","LU2112291526.USD","BK4581","LU1023059063.AUD","BK4585","IBB","BIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662813780","title":"Analysts Offer Insights on Healthcare Companies: Verrica Pharmaceuticals (VRCA) and Amgen (AMGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2662813780","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662813780?lang=en_us&edition=fundamental","pubTime":"2026-08-27 23:20","pubTimestamp":1787844046,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Verrica Pharmaceuticals (VRCA) and Amgen (AMGN). Verrica Pharmace...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-verrica-pharmaceuticals-vrca-and-amgen-amgn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-verrica-pharmaceuticals-vrca-and-amgen-amgn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BIB","IE00B4R5TH58.HKD","BK4137","HCSG","LU2242646821.SGD","LU1571399168.USD","BK4585","SG9999001440.SGD","IE0009355771.USD","BK4139","IE00BFTCPJ56.SGD","LABU","LU0128526141.USD","BK4599","BBH","LU0868494617.USD","LU0058720904.USD","LU2468319806.SGD","IE0002141913.USD","XLV","BK4588","LU0320765992.SGD","LU0122379950.USD","AMGN","LU1023059063.AUD","LU2112291526.USD","PBE","LU0889565916.HKD","TBXU","LU1983299246.USD","LU0289739699.SGD","VRCA","PJP","LU0109394709.USD","LU1057294990.SGD","BK4533","IE00B2B36J28.USD","LU2089984988.USD","BK4581","IBB","IBBQ","XBI","LU2242652126.USD","BK4534","IE00BJT1NW94.SGD","BK4566","IE00BJJMRZ35.SGD","LU0029874061.USD","BK4007","LU1061106388.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662084083","title":"HBM Holdings FY26 H1 Profit Falls 11.16% to US$ 64.85 Million; Revenue Rises 20.9% to US$ 122.49 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2662084083","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662084083?lang=en_us&edition=fundamental","pubTime":"2026-08-27 22:01","pubTimestamp":1787839287,"startTime":"0","endTime":"0","summary":"HBM Holdings FY26 H1 profit falls 11.16% to US$ 64.85 million; revenue rises 20.9% to US$ 122.49 millionHBM Holdings posted revenue of US$122.49 million for the six months ended June 30, 2026, up 20.9","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nNDL77D5HK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2089984988.USD","PJP","LU0109394709.USD","IBBQ","02142","LU1061106388.HKD","LU1983299246.USD","BK1161","BK4585","BIB","BK4566","LU0289739699.SGD","BK4588","IE00B2B36J28.USD","LU0058720904.USD","LU1023059063.AUD","AMGN","IE0002141913.USD","PBE","SG9999001440.SGD","IE00BFTCPJ56.SGD","BK4139","IE00BJJMRZ35.SGD","BK4533","LU2242652126.USD","BK4581","BK1574","LU2468319806.SGD","LU0320765992.SGD","BK4599","LU0122379950.USD","LU1571399168.USD","IE0009355771.USD","IBB","LU1057294990.SGD","BBH","TBXU","LU2112291526.USD","BK1583","BK4534","LU0889565916.HKD","LU0868494617.USD","IE00BJT1NW94.SGD","LU2242646821.SGD","IE00B4R5TH58.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662013447","title":"Amgen, AstraZeneca announce Crossing trial showed ‘meaningful’ improvements","url":"https://stock-news.laohu8.com/highlight/detail?id=2662013447","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662013447?lang=en_us&edition=fundamental","pubTime":"2026-08-27 19:15","pubTimestamp":1787829352,"startTime":"0","endTime":"0","summary":"Positive high-level results from the Phase III CROSSING trial in patients with eosinophilic esophagitis showed that AstraZeneca (AZN) and Amgen’s (...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/amgen-astrazeneca-announce-crossing-trial-showed-meaningful-improvements-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/amgen-astrazeneca-announce-crossing-trial-showed-meaningful-improvements-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBBQ","LU0708994859.HKD","IE0002141913.USD","LU2236285917.USD","BK4533","BK4007","IE00BJT1NW94.SGD","LU2456880835.USD","LU0029864427.USD","LU1829250122.USD","BK4534","LU0432979614.USD","LU1267930573.SGD","LU2237443382.USD","BK4588","LU0122379950.USD","LU2089984988.USD","PBE","BBH","AZN","PJP","IE00BJJMRZ35.SGD","LU1057294990.SGD","LU2417539215.USD","LU2462157665.USD","AZNH","LU2237443622.USD","LU2237443465.HKD","LU2468319806.SGD","IE00BFTCPJ56.SGD","LU2242652126.USD","LU1023059063.AUD","IE00B4R5TH58.HKD","LU0868494617.USD","BK4139","BIB","TBXU","LU0128525929.USD","BK4568","IE0009355771.USD","BK4581","LU0289739699.SGD","BK4566","IBB","BK4585","LU2242646821.SGD","IE00B3T34201.USD","AMGN","IE00B2B36J28.USD","LU2237443978.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662877754","title":"Amgen, AstraZeneca report CROSSING trial met co-primary and secondary endpoints","url":"https://stock-news.laohu8.com/highlight/detail?id=2662877754","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662877754?lang=en_us&edition=fundamental","pubTime":"2026-08-27 17:15","pubTimestamp":1787822113,"startTime":"0","endTime":"0","summary":"Amgen (AMGN) and AstraZeneca (AZN) announced top-line results from the Phase 3 CROSSING trial of Tezspire in patients living with eosinophilic esop...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/amgen-astrazeneca-report-crossing-trial-met-co-primary-and-secondary-endpoints-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/amgen-astrazeneca-report-crossing-trial-met-co-primary-and-secondary-endpoints-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2237443465.HKD","LU0432979614.USD","LU2242646821.SGD","IE00B3T34201.USD","LU0122379950.USD","PBE","IBB","LU0889565916.HKD","LU0289739699.SGD","BK4007","LU0128525929.USD","LU1267930573.SGD","LU2236285917.USD","LU2237443978.SGD","BK4566","BK4568","IE0009355771.USD","IE00BFTCPJ56.SGD","LU2112291526.USD","TBXU","LU0058720904.USD","IE0002141913.USD","BIB","LU0868494617.USD","IBBQ","AMGN","IE00B2B36J28.USD","AZNH","LU2417539215.USD","BBH","LU1571399168.USD","BK4581","LU0320765992.SGD","PJP","LU2468319806.SGD","BK4585","LU1023059063.AUD","LU2237443895.HKD","LU2456880835.USD","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","LU1983299246.USD","LU1829250122.USD","AZN","LU1061106388.HKD","BK4588","BK4533","LU0029864427.USD","LU1057294990.SGD","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662771175","title":"AstraZeneca, Amgen Phase 3 Trial Shows Tezspire Eases Swallowing Difficulties for EoE Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2662771175","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662771175?lang=en_us&edition=fundamental","pubTime":"2026-08-27 16:24","pubTimestamp":1787819085,"startTime":"0","endTime":"0","summary":"AstraZeneca  and Amgen  said Thursday their drug Tezspire met the primary endpoints of a Phase 3 trial treating eosinophilic esophagitis, a chronic inflammatory esophagus disorder.The medication met both primary endpoints by reducing tissue inflammation and easing swallowing difficulties at week 24 compared to a placebo, the companies said.The disease and symptom improvements were maintained through week 52 for both tested doses, they said.The companies also said the safety profile of the treatment during the study remained consistent with its previously approved uses.Shares of Amgen were down by over 1% in Thursday premarket activity.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TBXU","AZNH","IE00B4R5TH58.HKD","BK4534","LU2462157665.USD","LU2237443622.USD","LU2242652126.USD","LU0058720904.USD","LU0889565916.HKD","BBH","LU2242646821.SGD","BK4533","PJP","LU0708994859.HKD","BK4585","LU2089984988.USD","LU2237443465.HKD","LU1057294990.SGD","LU1061106388.HKD","LU2237443978.SGD","LU2112291526.USD","LU2237443895.HKD","LU0128525929.USD","LU1267930573.SGD","BK4566","IE00BJT1NW94.SGD","LU2456880835.USD","IE00BFTCPJ56.SGD","LU0432979614.USD","LU1829250122.USD","BK4599","LU0029864427.USD","LU0310800379.SGD","AMGN","BIB","BK4581","IBBQ","AZN","IBB","LU0109394709.USD","LU2237443382.USD","LU0868494617.USD","LU1571399168.USD","IE00B2B36J28.USD","PBE","BK4007","LU2237443549.SGD","LU1983299246.USD","IE00BJJMRZ35.SGD","LU0289739699.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":200,"code":"91000000","status":"200"}]}}